SCHEMBL7985375

SCHEMBL7985375

NC(=O)c1c(NC(=O)c2ccccc2F)ncn1Cc1cccc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
MAPT P10636 3/20 0.45
POLB P06746 1/20 0.45
FSCN1 Q16658 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
YTHDC1 Q96MU7 1/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
TP53 P04637 1/20 0.44
ADRA1D P25100 1/20 0.43
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
RAB9A P51151 1/20 0.42
KCNMA1 Q12791 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
SIRT1 Q96EB6 1/20 0.42
SIRT3 Q9NTG7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991521 0.91 ADORA3 (0.47) KDM4EMAPTPOLBRXFP1SMN1; SMN2
SCHEMBL7987851 0.87 LMNA (0.46) MAPTPOLBFSCN1RXFP1SMN1; SMN2
SCHEMBL7974040 0.86 KDM4E (0.51) KDM4EALDH1A1YTHDC1TSHRADRA1D
SCHEMBL7988637 0.86 NPC1 (0.51) KDM4EMAPTPOLBSMN1; SMN2ALDH1A1
SCHEMBL7991269 0.85 TP53 (0.46) KDM4EMAPTPOLBRXFP1SMN1; SMN2
SCHEMBL7984492 0.83 ADORA2A (0.53) KDM4EALDH1A1YTHDC1AURKAAURKB
SCHEMBL7988763 0.82 NR1H4 (0.43) KDM4EMAPTSMN1; SMN2ALDH1A1TDP1
SCHEMBL7987920 0.82 TP53 (0.47) KDM4EMAPTRXFP1SMN1; SMN2ALDH1A1
SCHEMBL7985708 0.82 NPC1 (0.49) KDM4EMAPTSMN1; SMN2ALDH1A1TSHR
SCHEMBL7974240 0.81 RAB9A (0.47) KDM4EMAPTPOLBSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed